Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.
Corominas H, Castellví I, Diaz-Torné C, Matas L, de la Rosa D, Mangues MA, Moya P, Pomar V, Benito N, Moga E, Sosa NH, Casademont J, Domingo P.
Corominas H, et al. Among authors: mangues ma.
Medicine (Baltimore). 2021 May 14;100(19):e25923. doi: 10.1097/MD.0000000000025923.
Medicine (Baltimore). 2021.
PMID: 34106658
Free PMC article.